Skip to content

The Effects of Auditory Cues on Gait Mechanics in Parkinson's Disease

The Effects of Auditory Cues on Gait Mechanics in Parkinson's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03253965
Enrollment
21
Registered
2017-08-18
Start date
2017-09-15
Completion date
2018-08-01
Last updated
2018-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Brief summary

The purpose of this study is to determine how using auditory cues of a metronome and music at various frequencies impacts the gait mechanics in people with Parkinson's disease when walking over ground and on a treadmill. The investigators will enroll a total of 40 participants: 30 subjects with a diagnosis of Parkinson's disease (10 in Stage 1, 10 in Stage 2, and 10 in Stage 3) and 10 unimpaired subjects. Participants will complete 7 different treadmill walking conditions and overground walking conditions while the investigators measure step length, cadence, gait speed, and variability of movement.

Interventions

OTHERMetronome Normal

Steps are timed with the beat of the metronome set to the subject's cadence

OTHERMetronome Slow

Steps are timed with the beat of the metronome set to 85% of the subject's cadence

OTHERMetronome Fast

Steps are timed with the beat of the metronome set to 115% of the subject's cadence

OTHERMusic Normal

Steps are timed with the beat of the music by a rhythm consistent with the subject's cadence

OTHERMusic Slow

Steps are timed with the beat of the music by a rhythm consistent with 85% of the subject's cadence

OTHERMusic Fast

Steps are timed with the beat of the music by a rhythm consistent with 115% of the subject's cadence

OTHERNo Auditory cueing

Steps are not timed with any auditory cue.

Sponsors

University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

10 unimpaired controls and 30 subjects with Parkinson's Disease (described in detail below - see inclusion/

Exclusion criteria

). The 30 subjects with Parkinson's Disease will be assigned into 3 groups (10 with H&Y Stage 1, 10 with H&Y Stage 2, and 10 with H&Y Stage 3). Inclusion Criteria: * Individuals with a diagnosis of Parkinson's Disease (made by movement disorders specialist) will be included in this study. Additional inclusion criteria include: self-reported ability to walk \>10 m overground as well as walk on a treadmill for a total of 14 minutes with rest breaks as needed, and be classified as Stage 1, 2, or 3 on the Hoehn and Yahr Scale since these stages have the most independence with mobility (Goetz et. al, 2004).

Design outcomes

Primary

MeasureTime frameDescription
Step LengthThe entire duration of each condition, approximately 2 minutes each.The length of each step taken while walking on a treadmill or overground. It is the anteroposterior distance from one foot to the other at heel strike measured during walking under each condition.

Secondary

MeasureTime frameDescription
CadenceThe entire duration of each condition, approximately 2 minutes each.The number of steps taken per minute measured while walking on a treadmill or overground under each condition.
Gait speedThe entire duration of each condition, approximately 2 minutes each.The distance covered in a measured period of time (meters per second) while walking overground under each condition.
Movement variabilityThe entire duration of each condition, approximately 2 minutes each.The coefficient of variation of spatiotemporal measures (step timing and step length) while walking overground and on a treadmill under each condition.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026